跳至主要内容
临床试验/NCT01711294
NCT01711294已完成不适用

A Multicenter, Prospective, Randomized Study on Endosonographic Evaluation of Pancreatic Cystic Lesions Using 22 G, 19 G, and Flexible 19 G Fine Needle Aspiration

Boston Scientific Corporation14 个研究点 分布在 3 个国家目标入组 250 人开始时间: 2013年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
250
试验地点
14
主要终点
Volume of Aspirated Cyst Fluid as a Function of Estimated Maximal Volume

研究概览

简要总结

To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of mucinous (pre-malignant) and non-mucinous cysts.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pancreatic cystic lesion measuring 13mm or greater in largest diameter.
  • Indicated for EUS evaluation of the PCL including EUS-FNA.
  • Age 18 years of age or older.
  • Willing and able to comply with the study procedures and provide written informed consent form to participate in the study.

排除标准

  • Cysts in which FNA is not indicated based on review by the clinician, including potential concern of blood vessel location relative to the cyst.
  • Requirement for anticoagulation using clopidogril, warfarin, or other long acting antiplatelet agents (with the exception of aspirin) that cannot be safely stopped according to institutional guidelines.
  • Standard contraindications for EUS.
  • Known pancreatic pseudocyst.
  • Pregnancy.

结局指标

主要结局

Volume of Aspirated Cyst Fluid as a Function of Estimated Maximal Volume

时间窗: At procedure (Up to 1 hour)

Volume of aspirated cyst fluid as a function of estimated maximal volume, based on pre-aspiration EUS measure of cyst diameter (s) (% aspiration of total estimated volume)

次要结局

  • Change in Volume of Cyst Post Initial Procedure Compared to Pre Procedure(Procedure (Up to 1 hour))
  • Number of Participants With Successful Echoendoscopic Fine Needle Aspiration of PCL(Procedure (up to 1 hour))
  • Number of EUS-FNA Needle Passes at Initial Procedure.(Procedure (Up to 1 hour))
  • Number of Needles With Needle Removal Rated as Excellent/Very Good(Procedure (Up to 1 hour))
  • Number of Needles With Needle Visualization Rated as Excellent/Very Good(Procedure (Up to 1 hour))
  • Number of Patients With Related Adverse Events(30 days)
  • Number of Participants With PCL Reached/Penetrated(Procedure (Up to 1 hour))
  • Number of EUS-FNA Needles Used at Initial Procedure.(Procedure (Up to 1 hour))
  • Number of Needles With Needle Insertion Rated as Excellent/Very Good(Procedure (Up to 1 hour))
  • Rate of Cross-over to Salvage Arm(Procedure (Immediate))
  • Number of Participants Requiring Post EUS-FNA Patient Management(30 days)
  • Number of Participants Whose Management Decision Was Directly Influenced by the EUS Findings(Procedure - 30 days after procedure)
  • Time Needed for Aspiration for Each Needle Pass at Initial Procedure.(Procedure (Up to 1 hour))
  • Time From First Needle Pass in to Last Needle Pass Out at Initial Procedure.(Procedure (Up to 1 hour))
  • Number of Participants With Accurate Diagnosis of the Disease State Using the EUS-FNA Needles(up to 2 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验